Clozapine-induced electroencephalogram changes as a function of clozapine serum levels

Oliver Freudenreich, Richard D. Weiner, Joseph Patrick McEvoy

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Specific electroencephalogram (EEG) changes during clozapine therapy were prospectively studied in a cohort of 50 chronic state hospital patients with schizophrenia who were randomly assigned to one of three nonoverlapping clozapine serum level ranges (50-150 ng/mL, 200-300 ng/mL, and 350-450 ng/mL). EEGs were obtained before clozapine was instituted, and after 10 weeks of treatment. Fifty-three percent of patients showed EEG changes during the 10-week study period. We observed three seizures (6%), one in a patient on 900 mg (serum level 320 ng/mL) clozapine, and two in patients with lower clozapine serum levels (200-300 ng/mL) who had prior histories of seizures and inadequate valproate coverage. Thirteen percent of patients developed spikes with no relationship to dose or serum level of clozapine. Fifty-three percent of patients developed slowing on EEG. Compared to plasma levels below 300 ng/mL, a clozapine serum level between 350 and 450 ng/mL led to more frequent and more severe slowing. The EEG slowing correlated with observed sleepiness, although this factor was not sufficient to explain the severity of high-dose effects.

Original languageEnglish (US)
Pages (from-to)132-137
Number of pages6
JournalBiological Psychiatry
Volume42
Issue number2
DOIs
StatePublished - Jul 15 1997

Fingerprint

Clozapine
Electroencephalography
Serum
Seizures
State Hospitals
Valproic Acid
Schizophrenia
Therapeutics

Keywords

  • Clozapine
  • Electroencephalogram
  • Schizophrenia
  • Seizures
  • Serum level

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. / Freudenreich, Oliver; Weiner, Richard D.; McEvoy, Joseph Patrick.

In: Biological Psychiatry, Vol. 42, No. 2, 15.07.1997, p. 132-137.

Research output: Contribution to journalArticle

Freudenreich, Oliver ; Weiner, Richard D. ; McEvoy, Joseph Patrick. / Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. In: Biological Psychiatry. 1997 ; Vol. 42, No. 2. pp. 132-137.
@article{5aa57a0c20114fed946455598a18b5ee,
title = "Clozapine-induced electroencephalogram changes as a function of clozapine serum levels",
abstract = "Specific electroencephalogram (EEG) changes during clozapine therapy were prospectively studied in a cohort of 50 chronic state hospital patients with schizophrenia who were randomly assigned to one of three nonoverlapping clozapine serum level ranges (50-150 ng/mL, 200-300 ng/mL, and 350-450 ng/mL). EEGs were obtained before clozapine was instituted, and after 10 weeks of treatment. Fifty-three percent of patients showed EEG changes during the 10-week study period. We observed three seizures (6{\%}), one in a patient on 900 mg (serum level 320 ng/mL) clozapine, and two in patients with lower clozapine serum levels (200-300 ng/mL) who had prior histories of seizures and inadequate valproate coverage. Thirteen percent of patients developed spikes with no relationship to dose or serum level of clozapine. Fifty-three percent of patients developed slowing on EEG. Compared to plasma levels below 300 ng/mL, a clozapine serum level between 350 and 450 ng/mL led to more frequent and more severe slowing. The EEG slowing correlated with observed sleepiness, although this factor was not sufficient to explain the severity of high-dose effects.",
keywords = "Clozapine, Electroencephalogram, Schizophrenia, Seizures, Serum level",
author = "Oliver Freudenreich and Weiner, {Richard D.} and McEvoy, {Joseph Patrick}",
year = "1997",
month = "7",
day = "15",
doi = "10.1016/S0006-3223(96)00298-3",
language = "English (US)",
volume = "42",
pages = "132--137",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Clozapine-induced electroencephalogram changes as a function of clozapine serum levels

AU - Freudenreich, Oliver

AU - Weiner, Richard D.

AU - McEvoy, Joseph Patrick

PY - 1997/7/15

Y1 - 1997/7/15

N2 - Specific electroencephalogram (EEG) changes during clozapine therapy were prospectively studied in a cohort of 50 chronic state hospital patients with schizophrenia who were randomly assigned to one of three nonoverlapping clozapine serum level ranges (50-150 ng/mL, 200-300 ng/mL, and 350-450 ng/mL). EEGs were obtained before clozapine was instituted, and after 10 weeks of treatment. Fifty-three percent of patients showed EEG changes during the 10-week study period. We observed three seizures (6%), one in a patient on 900 mg (serum level 320 ng/mL) clozapine, and two in patients with lower clozapine serum levels (200-300 ng/mL) who had prior histories of seizures and inadequate valproate coverage. Thirteen percent of patients developed spikes with no relationship to dose or serum level of clozapine. Fifty-three percent of patients developed slowing on EEG. Compared to plasma levels below 300 ng/mL, a clozapine serum level between 350 and 450 ng/mL led to more frequent and more severe slowing. The EEG slowing correlated with observed sleepiness, although this factor was not sufficient to explain the severity of high-dose effects.

AB - Specific electroencephalogram (EEG) changes during clozapine therapy were prospectively studied in a cohort of 50 chronic state hospital patients with schizophrenia who were randomly assigned to one of three nonoverlapping clozapine serum level ranges (50-150 ng/mL, 200-300 ng/mL, and 350-450 ng/mL). EEGs were obtained before clozapine was instituted, and after 10 weeks of treatment. Fifty-three percent of patients showed EEG changes during the 10-week study period. We observed three seizures (6%), one in a patient on 900 mg (serum level 320 ng/mL) clozapine, and two in patients with lower clozapine serum levels (200-300 ng/mL) who had prior histories of seizures and inadequate valproate coverage. Thirteen percent of patients developed spikes with no relationship to dose or serum level of clozapine. Fifty-three percent of patients developed slowing on EEG. Compared to plasma levels below 300 ng/mL, a clozapine serum level between 350 and 450 ng/mL led to more frequent and more severe slowing. The EEG slowing correlated with observed sleepiness, although this factor was not sufficient to explain the severity of high-dose effects.

KW - Clozapine

KW - Electroencephalogram

KW - Schizophrenia

KW - Seizures

KW - Serum level

UR - http://www.scopus.com/inward/record.url?scp=0030944756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030944756&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(96)00298-3

DO - 10.1016/S0006-3223(96)00298-3

M3 - Article

VL - 42

SP - 132

EP - 137

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -